ARIAD Announces Webcast of Its Annual Shareholders Meeting
June 11 2014 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
its Annual Meeting of Stockholders will be webcast live on June 25,
2014 and can be accessed by visiting the investor relations section
of the Company’s website at: http://www.ariad.com/investor.
The annual meeting will take place at 10:00 a.m. (EDT) at the
Company’s offices in Cambridge, Massachusetts and will include an
overview of ARIAD and its key programs provided by Harvey J.
Berger, M.D., chairman and chief executive officer of ARIAD, and
key members of senior management. A replay will be available on the
investor page of the ARIAD website approximately three hours after
the presentation and will be archived for four weeks. To ensure a
timely connection to the live webcast, participants should log on
at least five minutes prior to the scheduled start time.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts and Lausanne, Switzerland, is an integrated global
oncology company focused on transforming the lives of cancer
patients with breakthrough medicines. ARIAD is working on new
medicines to advance the treatment of various forms of chronic and
acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer
medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc.For InvestorsKendra Adams,
617-503-7028kendra.adams@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2023 to Sep 2024